Chawla Lakhmir S 4
4 · LA JOLLA PHARMACEUTICAL CO · Filed Aug 18, 2020
Insider Transaction Report
Form 4
Chawla Lakhmir S
Chief Medical Officer
Transactions
- Award
Common Stock
2020-08-14$3.34/sh+589$1,967→ 12,611 total - Award
Employee Stock Option (Right to Buy)
2020-08-14+589→ 589 totalExercise: $3.93Exp: 2030-08-14→ Common Stock (589 underlying)
Footnotes (2)
- [F1]These shares were acquired on 08/14/2020 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]The stock options vest and become exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vest and become exercisable ratably on a monthly basis over the next three years.